CN Stock MarketDetailed Quotes

603538 Ningbo Menovo Pharmaceutical

Watchlist
  • 13.09
  • +0.19+1.47%
Market Closed Dec 27 15:00 CST
2.86BMarket Cap140.75P/E (TTM)

Ningbo Menovo Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Ningbo Menovo Pharmaceutical Q3 2024 Earnings Date

Currency：CNYOct 30, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
341.20M
--
-1.46%
EPS
--
0.19
--
--
Analyst Rating
Buy

Dec 28, 2024

Ningbo Menovo Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.985B--
--2024/FY-- / 1.481B--
--2023/FY1.216B / 1.495B--
--2022/FY1.457B / 1.695B--
--2021/FY1.258B / 1.233B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.985B--
--2024/FY-- / 1.481B--
--2023/FY1.216B / 1.495B--
--2022/FY1.457B / 1.695B--
--2021/FY1.258B / 1.233B--

Unlock Free Earnings Estimates

Ningbo Menovo Pharmaceutical Earnings Reports

  • Ningbo Menova Pharmaceutical Co., Ltd. Report for the Third Quarter of 2024

    Oct 29 12:00 ET

  • Ningbo Menova Pharmaceutical Co., Ltd. 2024 Semi-Annual Report

    Aug 30 12:00 ET

  • Summary of the 2024 semi-annual report of Ningbo Menova Pharmaceutical Co., Ltd.

    Aug 30 12:00 ET

  • Ningbo Menova Pharmaceutical Co., Ltd. 2024 First Quarter Report

    Apr 29 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 28, 2024

    Buy

    • Strong Buy

      25.00%

    • Buy

      75.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme The Pet Economy
    The Pet Economy
    Intraday+1.24%
    Assisted Reproduction
    Assisted Reproduction
    Intraday+0.73%
    Virus Prevention
    Virus Prevention
    Intraday+0.51%